אדבגרף 0.5 מג
astellas pharma international b.v., israel - tacrolimus as monohydrate - קפסולות בשחרור ממושך - tacrolimus as monohydrate 0.5 mg - tacrolimus
אדבגרף 1 מג
astellas pharma international b.v., israel - tacrolimus as monohydrate - קפסולות בשחרור ממושך - tacrolimus as monohydrate 1 mg - tacrolimus
אדבגרף 3 מג
astellas pharma international b.v., israel - tacrolimus as monohydrate - קפסולות בשחרור ממושך - tacrolimus as monohydrate 3 mg - tacrolimus
אדבגרף 5 מג
astellas pharma international b.v., israel - tacrolimus as monohydrate - קפסולות בשחרור ממושך - tacrolimus as monohydrate 5 mg - tacrolimus
דייליפורט 0.5 מג
novartis israel ltd - tacrolimus as monohydrate - קפסולות בשחרור ממושך - tacrolimus as monohydrate 0.5 mg - tacrolimus
דייליפורט 1 מג
novartis israel ltd - tacrolimus as monohydrate - קפסולות בשחרור ממושך - tacrolimus as monohydrate 1 mg - tacrolimus
דייליפורט 3 מג
novartis israel ltd - tacrolimus as monohydrate - קפסולות בשחרור ממושך - tacrolimus as monohydrate 3 mg - tacrolimus
דייליפורט 5 מג
novartis israel ltd - tacrolimus as monohydrate - קפסולות בשחרור ממושך - tacrolimus as monohydrate 5 mg - tacrolimus
סרטיקן ® 0.1 מ"ג טבליות מסיסות
novartis pharma services ag - everolimus 0.1 mg - tablets dispersible - everolimus - kidney and heart transplantationcertican® is indicated for the prophylaxis of organ rejection in adult patients at low to moderate immunological risk receiving an allogeneic renal or cardiac transplant. in kidney and heart transplantation, certican should be used in combination with ciclosporin for microemulsion and corticosteroids.liver transplantationcertican is indicated for the prophylaxis of organ rejection in patients receiving a hepatic transplant. in liver transplantation, certican should be used in combination with tacrolimus and corticosteroids.
סרטיקן ® 0.25 מ"ג טבליות מסיסות
novartis pharma services ag - everolimus 0.25 mg - tablets dispersible - everolimus - kidney and heart transplantationcertican® is indicated for the prophylaxis of organ rejection in adult patients at low to moderate immunological risk receiving an allogeneic renal or cardiac transplant. in kidney and heart transplantation, certican should be used in combination with ciclosporin for microemulsion and corticosteroids.liver transplantationcertican is indicated for the prophylaxis of organ rejection in patients receiving a hepatic transplant. in liver transplantation, certican should be used in combination with tacrolimus and corticosteroids.